Thymomas are tumors of thymic epithelial cells. They associate more often than any other human tumors with various autoimmune diseases; myasthenia gravis is the commonest, occurring in 10-50% of thymoma patients, depending on the World Health Organization-defined histologic subtype. Most thymomas generate many polyclonal maturing T lymphocytes but in disorganized microenvironments Failure to induce self-tolerance may be a key factor leading to the export of potentially autoreactive CD4 progeny, thus predisposing to autoimmune diseases. Normally, the master Autoimmune Regulator promotes expression of peripheral tissue-restricted antigens such as insulin by medullary thymic epithelial cells and induction of tolerance to them. The failure of ∼95% of thymomas to express autoimmune regulator is another feature potentially contributing to autoimmunity. © 2010 by the International Association for the Study of Lung Cancer.
CITATION STYLE
Marx, A., Hohenberger, P., Hoffmann, H., Pfannschmidt, J., Schnabel, P., Hofmann, H. S., … Ströbel, P. (2010). The autoimmune regulator AIRE in thymoma biology: Autoimmunity and beyond. Journal of Thoracic Oncology, 5(10 SUPPL. 4). https://doi.org/10.1097/JTO.0b013e3181f1f63f
Mendeley helps you to discover research relevant for your work.